CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 9 No. 5
The Milsom/Hammerhofer Article Reviewed 

Role of Laparoscopic Techniques in Colorectal Cancer Surgery

By Robert W. Beart, Jr., MD, And Adrian Ortega, MD, University of Southern California Center for Colorectal Diseases, Los Angeles | May 1, 1995

The authors have nicely reviewed many of the issues surrounding laparoscopic colon cancer surgery. However, we would like to offer a slightly different perspective on several points which they make.

As the authors point out, laparoscopic colon resection is a new, evolving technology, the role of which is unclear. The fact that one can do this operation laparoscopically does not necessarily mean that it is a good idea. In general, most authors who have published papers on this issue have found technical advantages to performing the procedure laparoscopically [1-3]. When colon resection is performed laparoscopically, it would appear that most patients have less pain, more rapid return of bowel function, shorter hospital stay, and more rapid return to full and normal functioning. However, most of these series are not randomized and may have a strong selection bias. Therefore, a randomized prospective study needs to be carried out to confirm this impression.

Physiology of Laparoscopic Resection

The physiology of laparoscopic colon resection may differ substantially from that of the open procedure. There appears to be a greater stress response during laparoscopic surgery but a more rapid return to normal stress hormone levels in the postoperative period. In addition, hypercarbia alters peripheral perfusion and cardiac output. In general, cardiac patients may tolerate a laparoscopic procedure better than when an open procedure is performed. However, the use of carbon dioxide for insufflation may make it difficult for patients with pulmonary diffusion abnormalities to maintain an adequate acid-base balance during laparoscopic surgery.

Similarly, immune function may be better preserved by laparoscopic surgery. Initial studies by Senagore and others suggest that interleukin-6 levels are maintained in a more normal range and the acute immune reaction is much less intense when the colon is removed laparoscopically than when it is removed in an open procedure [3-8]. If laparoscopic resection does minimize immunosuppression, patients may have less recurrent cancer and lower infection rates.

No Inordinate or Unusual Risks

Concerns have been raised about port site recurrences [4,9]. Although a number of these complications have been reported in the literature, only one article offers a denominator by which to judge the probable incidence of port site recurrence [10]. In this article, with a minimum of 1 year of follow-up, the incidence of port site recurrence appears to be less than 2%. Therefore, although this is an issue that needs to be evaluated, at present there is no evidence to suggest that there are inordinate or unusual risks posed by removing colon cancer laparoscopically.

Several studies have evaluated the costs of laparoscopic colon resection. In all cases, the increased intraoperative costs have been at least balanced by the decreased length of stay of the patient population. In studies in which the surgeon is more experienced and operative time is decreased, laparoscopic surgery generally is less expensive than open surgery.

In summary, this is an interesting technology that deserves to be fully explored. It would be unfortunate if isolated observations or concerns were to compromise the complete evaluation of this procedure, which is critical to determining whether it offers any advantage to patients who traditionally would undergo an open resection. The randomized prospective studies outlined by the authors should be completed, and should enjoy the support of the entire medical community, so as to answer this question as quickly as possible.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Jeffrey W. Milsom, MD, and Katherine A. Hammerhofer, RN


1. Beart RW: Laparoscopic colectomy. Dis Colon Rectum 37(suppl):S47-S49, 1994.

2. Frazee RC, Roberts JW, Symonds RE, et al: A prospective randomized trial comparing open versus laparoscopic appendectomy. Ann Surg 219:725-731, 1994.

3. Kwok SPY, Lau WY, Li AKC: Prospective comparison of laparoscopic and conventional anterior resection (reply). Br J Surg 81:625, 1994.

4. Cirocco WC, Schwartzman A, Golub RW: Abdominal wall recurrence after laparoscopic colectomy for colon ca. Surgery 116:842-846, 1994.

5. Colacchio TA, Yeager MP, Hildebrandt LW: Perioperative immunomodulation in cancer surgery. Am J Surg 167:174-179, 1994.

6. Harmon GD, Senagore AJ, Kilbride MJ, et al: Interleukin-6 response to laparoscopic and open colectomy. Dis Colon Rectum 37:754-759, 1994.

7. Kloosterman T, Von Blomberg ME, Borgstein P, et al: Unimpaired immune functions after laparoscopic cholecystectomy. Surgery 115:424-428, 1994.

8. Patel RT, Deen KI, Youngs D, et al: IL-6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 81:1306-1308, 1994.

9. Nelson H: Laparoscopic and colon cancer: Is the port site at risk? A preliminary report (invited commentary). Arch Surg 129:900, 1994.

10. Ramos JM, Gupta S, Anthone GJ, et al: Laparoscopic and colon cancer: Is the port site at risk? Arch Surg 129:897-899, 1994.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy